Century Therapeutics, Inc. (IPSC)
1.53
-0.08
(-4.97%)
USD |
NASDAQ |
Oct 02, 16:00
1.53
0.00 (0.00%)
Pre-Market: 20:00
Century Therapeutics Profit Margin (Quarterly)
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2025 | 70.13% |
| December 31, 2024 | -864.4% |
| September 30, 2024 | -3.95K% |
| June 30, 2024 | -4.05K% |
| March 31, 2024 | -3.28K% |
| December 31, 2023 | -14.70K% |
| September 30, 2023 | -22.11K% |
| Date | Value |
|---|---|
| June 30, 2023 | -33.63K% |
| March 31, 2023 | -1.82K% |
| December 31, 2022 | -6.08K% |
| September 30, 2022 | -1.38K% |
| June 30, 2022 | -2.22K% |
| March 31, 2022 | -3.55K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Tenax Therapeutics, Inc. | -- |
| Exicure, Inc. | -- |
| Absci Corp. | -10.44K% |
| Celularity, Inc. | 17.55% |
| Cardio Diagnostics Holdings, Inc. | -27.81K% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -52.67% |
| Return on Assets | -40.17% |
| Return on Invested Capital | -43.26% |
| Return on Net Operating Assets | -107.6% |